Biotechnology

Pressure BioSciences UST-Enabled Nanoemulsions Soar Past One Year Stability Goal; Results Open Explosive Growth Potential for Water-Soluble CBD-Infused Beverages Worldwide

July 13, 2021 8:57 AM

UST Nanoemulsions of CBD Deliver High Water-Solubility and Over One Year Storage Stability with No Degradation; UST Platform Primed to Revolutionize Food & Beverage, Biotherapeutic, Nutraceutical, and Agrochem Products SOUTH EASTON, MA / ACCESSWIRE / July 13, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and innovative...

Read more

Applied UV, Inc. Announces Pricing of $12.0 Million Public Offering of 10.5% Series A Cumulative Perpetual Preferred Stock

July 13, 2021 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / July 13, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultra violet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced the pricing of its underwritten registered public offering of 480,000 shares of 10.5% Series A Cumulative Perpetual Preferred Stock, with liquidation...

Read more

ReShape Lifesciences(TM) Launches Online Consumer Marketplace Offering Products Supporting Four Key Dimensions of Wellness: Nutrition, Exercise, Sleep and Stress

July 13, 2021 8:30 AM

SAN CLEMENTE, CA / ACCESSWIRE / July 13, 2021 / ReShape Lifesciences Inc. (NASDAQ:RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced the launch of ReShape Marketplace ™ as an extension of reshape care ™, the company's reimbursed telehealth service for weight loss across any physician prescribed therapy. ReShape Marketplace provides consumers with a collection of creative, competitively priced,...

Read more

Edesa Biotech Extends Dermatitis Study to Canada

July 13, 2021 8:10 AM

TORONTO, ON / ACCESSWIRE / July 13, 2021 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related diseases, today announced that the company has expanded patient enrollment to Canada for the final part of a Phase 2b study evaluating its EB01 drug candidate as a monotherapy for chronic Allergic Contact Dermatitis (Eczema), or ACD. The first part of the ACD study was conducted in...

Read more

Nascent Biotech and Manhattan BioSolutions Announce Promising Prelim/Preclinical Results in BCG-Based COVID-19 Vaccine Research Collaboration

July 13, 2021 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / July 13, 2021 / Nascent Biotech, Inc. (OTCQB:NBIO) ("Nascent Biotech", "Nascent", or the "Company"), a biotechnology company pioneering innovative medicines to overcome difficult-to-treat cancers and viral infections, and its collaboration partner, Manhattan BioSolutions (together, the "Partners"), are pleased to announce promising new preliminary preclinical results for the COVID-19 vaccine candidate now progressing...

Read more

Lexaria Receives Patent Protection in Japan

July 13, 2021 7:05 AM

New patent granted in Japan adds to existing patents in the EU, the U.S., India and Australia KELOWNA, BC / ACCESSWIRE / July 13, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces an additional expansion of its intellectual property portfolio with its first-ever patent granted in Japan. The patent is titled "Stable ready-to-drink beverage...

Read more

Applied UV to Present at the Ladenburg Thalmann Virtual Healthcare Conference

July 9, 2021 9:00 AM

MOUNT VERNON, NY / ACCESSWIRE / July 9, 2021 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection control technology company that applies the power of narrow-range ultraviolet light ("UVC") for surface areas and catalytic bioconversion technology for air purification to destroy pathogens safely, thoroughly, and automatically, announced the Company's management team will participate in the Ladenburg Thalmann Virtual...

Read more

Hancock Jaffe to Present at the Ladenburg Thalmann 2021 Healthcare Conference

July 8, 2021 9:05 AM

Live webcast on Tuesday, July 13th at 1:00 PM ET IRVINE, CA / ACCESSWIRE / July 8, 2021 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) ("Hancock Jaffe" or the "Company"), a developer of medical devices that restore cardiac and vascular health, today announced that Robert Berman, CEO of Hancock Jaffe will present at the Ladenburg Thalmann 2021 Healthcare Conference on Tuesday, July 13, 2021 at 1:00 PM ET. In addition to the presentation,...

Read more

Phyto Extractions' RV Visits Retailers in Cross-Country Tour

July 8, 2021 7:00 AM

LANGLEY, BC / ACCESSWIRE / July 8, 2021 / Phyto Extractions Inc. (formerly, Adastra Labs Holdings Ltd.) (CSE:XTRX)(Frankfurt:D2EP) ("Phyto Extractions™, "Phyto" or the "Company") strives to continuously bring consumers new and innovative products to enhance their experience and overall enjoyment. Phyto Extractions™' is known for its iconic concentrate product - Shatter and brand success as it was built during the legacy or "grey" market era....

Read more

Viewpoint Molecular Targeting(R) Partners with Industry Leader Pepscan to Accelerate Peptide Discovery Program

July 7, 2021 9:05 AM

Companies forge relationship to accelerate peptide drug discovery for next-generation radiopharmaceuticals  Pepscan brings proprietary world-leading peptide drug discovery expertise and technologies  Viewpoint to apply expertise in radiopharmaceuticals, chelation technologies and bioconjugate chemistry to accelerate the pace of discovery to clinic-ready radiopharmaceuticals  CORALVILLE, IA / ACCESSWIRE / July 7, 2021 / Viewpoint Molecular...

Read more

RepliCel Applies for Manufacturing Approval for Its Collagen and Tissue Regeneration Cell Therapies

July 7, 2021 6:00 AM

Clinical development of RepliCel's skin rejuvenation and tendon regeneration injectables continues to meet milestones on path to commercialization in Japan VANCOUVER, BC / ACCESSWIRE / July 7, 2021 / RepliCel Life Sciences Inc. (OTC PINK:REPCF)(TSXV:RP)(FSE:P6P2) ("RepliCel" or the "Company"), a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce it has submitted its application to Japan's...

Read more

Liviana CBD Infused Extra Virgin Olive Oil E-Commerce Now Open for Business

July 6, 2021 9:00 AM

CAPE TOWN, SA / ACCESSWIRE / July 6, 2021 / WUHAN GENERAL GROUP, INC. (OTC PINK:WUHN) ("Wuhan'' or the "Company"), a bioceutical company focused on alternative plant-based cannabinoids and psilocybin medical research is pleased to share the following update regarding its LivianaTM brand focused on creating premium CBD olive oils: LivianaTM is delighted to announce the opening of its e-commerce website. The website allows for easy and seamless...

Read more

FDA Grants Priority Review for Levo Therapeutics' New Drug Application for LV-101 (Intranasal Carbetocin) for the Treatment of Prader-Willi Syndrome

July 6, 2021 8:00 AM

CHICAGO, IL / ACCESSWIRE / July 6, 2021 / Levo Therapeutics, Inc., a biotechnology company dedicated to using genetic insights to advance treatments for Prader-Willi syndrome (PWS) and related disorders, announced today that the U.S. Food and Drug Administration (FDA) has granted Priority Review for its New Drug Application (NDA) for LV-101 (intranasal carbetocin) as a treatment for hyperphagia and behavioral distress associated with PWS. FDA...

Read more

Lexaria Announces Voluntary Delisting from the Canadian Securities Exchange to Concentrate Trading on the Nasdaq Capital Markets

July 5, 2021 8:00 AM

KELOWNA, BC / ACCESSWIRE / July 5, 2021 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW)(CSE: LXX) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces that on June 30, 2021 it made a request to voluntarily delist its common shares from the Canadian Securities Exchange (the “CSE”). It is expected that the close of business on Wednesday, July 7, 2021 will be the final trading day for Lexaria on the CSE. At...

Read more

Fuse Science, Inc. Shareholder Update and Announcement of Kustomeroo

July 2, 2021 2:20 AM

JACKSONVILLE, FL / ACCESSWIRE / July 2, 2021 / Fuse Science, Inc.(OTC PINK:DROP), The company is pleased to announce Kustomeroo is coming as part of Fuse Science, Inc (DROP). David Delke founder of Kustomeroo will work to keep everyone updated via formal channels as well as Twitter @daviddelke, @kustomeroo and https://kustomeroo.com . The company will have an investor and shareholder event on Twitch https://www.twitch.tv/kustomeroo on Wednesday,...

Read more

Vitro Biopharma Inc. April 30, 2021; 2nd Quarter ended Financial Results of Operations and Shareholder Letter

July 1, 2021 3:00 PM

GOLDEN, CO / ACCESSWIRE / July 1, 2021 / Vitro Biopharma Inc. (formerly Vitro Diagnostics Inc.) (dba Vitro Biopharma), announced its quarter ended April 30, 2021, financial results of operations. Vitro Biopharma recorded record quarter ended April 30, 2021 revenues of $ 326,535 vs $128,632 an increase of 254% over the prior comparative quarter directly attributed to recovering from the COVID-19 pandemic. Revenues in the second quarter of 2021 of...

Read more

Black Bird Biotech, Inc. (BBBT) Announces Application to Uplist To OTCQB Venture Market

July 1, 2021 8:30 AM

FLOWER MOUND, TX / ACCESSWIRE / July 1, 2021 / Black Bird Biotech, Inc. (OTC PINK:BBBT), manufacturer of plant-based MiteXstreamTM biopesticide, today announced that it has submitted its application to uplist to the OTCQB Venture Market. The company's management believes uplisting its common stock to the OTCQB will serve to improve the company's position in the public markets and substantially increase its visibility to a wider range of...

Read more

Pressure BioSciences Novel UST Platform Delivers Breakthrough Nanoemulsion Processing for One of the World's Most Potent Antioxidants - Astaxanthin

July 1, 2021 8:08 AM

Unprecedentedly Tiny, Uniform, and Stable Nanoemulsified Oil Droplets Containing Astaxanthin Expected to Significantly Increase Oral and Topical Absorption of this Antioxidant 6,000x More Powerful Than Vitamin C SOUTH EASTON, MA / ACCESSWIRE / July 1, 2021 / Pressure BioSciences, Inc. (OTCQB:PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology...

Read more

Helix BioPharma Corp. Announces Changes to the Company's Board of Directors and Management

June 30, 2021 5:00 PM

RICHMOND HILL, ON / ACCESSWIRE / June 30, 2021 / Helix BioPharma Corp. (TSX:HBP) ('Helix' or the 'Company'), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced that Heman Chao has notified the Board of Directors of the Company of his intention to step down from the position of Chief Executive Officer ("CEO"), Chief Scientific Officer ("CSO") and member of the Board,...

Read more

Thermic Science Receives its First North American Shipment of Thermic Infrared Heating Paint for Manufacturing the First Batch of North American Made Thermic Infrared Portable Heaters for Retail Consumer Sales and Distribution Across North America, Confirms ENDO/CSi-FR Acquisition

June 30, 2021 10:35 AM

NASHVILLE, TN / ACCESSWIRE / June 30, 2021 / Thermic Science International Corporation, formerly known as Omnicanna Health Solutions, Inc. aka ENDOCAN CORP. (WKN: A1W61J, ISIN: US29271J1097, OTC PINK:ENDO), is pleased to announce that the first shipment of the Thermic Infrared Heating Paint has cleared North American Customs and Border Services and has been recently received in North America to begin North American manufacturing of the advanced...

Read more